top of page

業績（2026年）

Publications

  1. Sasaki Y, Matsunawa M, Hayashi H, Kawamata N, Nagao K, Kuroiwa K, Narita H, Okamura R, Shimada S, Watanuki M, Arai N, Kawaguchi Y, Yanagisawa K, Hattori N. Comparison between Pola-R-CHP and R-CHOP regimens in patients newly diagnosed with diffuse large B-cell lymphoma: a propensity score-matched study. Sci Rep. 2026 Jun 26. doi: 10.1038/s41598-026-60010-1.

  2. Kataoka A, Yoshinaga N, Inoue Y, Toubai T, Uchida N, Ogura K, Uehara Y, Anzai N, Wakayama T, Wake A, Doki N, Tokunaga M, Eto T, Hattori N, Tanaka M, Watanabe M, Kamimura T, Kawamura K, Fukuda T, Ohbiki M, Atsuta Y, Nakasone H, Yakushijin K, Kanda J. Prognostic factors and a novel scoring system for allogeneic hematopoietic stem cell transplantation in patients aged 70 years or older: a nationwide registry analysis in Japan. Bone Marrow Transplant. 2026 Jun 11. doi: 10.1038/s41409-026-02870-9.

  3. Konuma T, Shimomura Y, Yamasaki S, Kondo T, Uchida N, Tanaka M, Takahashi S, Ogura K, Wake A, Kuriyama T, Takada S, Izumi T, Kozai Y, Uehara Y, Tokunaga M, Hattori N, Katayama Y, Kawamura K, Ishimaru F, Kanda J, Ohbiki M, Atsuta Y, Yanada M. Can Cord Blood Unit Selection Improve Outcomes After Single-Unit Unrelated Cord Blood Transplantation for Non-Remission Acute Myeloid Leukemia? Transplant Cell Ther. 2026;32(5):592-608.
    Tissue Cell. 2025 Feb;92:102634. doi: 10.1016/j.tice.2024.102634. PMID: 39615229

  4. Yamasaki S, Yanada M, Toubai T, Harada K, Tanaka M, Onizuka M, Nishida T, Hattori N, Izumi T, Takahashi S, Sawa M, Katayama Y, Kawakita T, Ishikawa J, Tokunaga M, Onodera K, Nagafuji K, Nakasone H, Ishimaru F, Kanda J, Atsuta Y, Konuma T. Conditioning-adapted methotrexate in cord blood transplantation for high-risk acute myeloid leukemia: a nationwide Japanese cohort analysis. Sci Rep. 2026 Jul 20. doi: 10.1038/s41598-026-63050-9. Online ahead of print.

  5. Yano H, Taruno K, Arai N, You S, Takeuchi M, Sakai H, Tsurutani J, Hattori N. Myeloid neoplasms post cytotoxic therapy (MN-pCT) following neoadjuvant chemotherapy in a patient with BRCA1 pathogenic variant-associated triple-negative breast cancer: a case report. Int Cancer Conf J. 2026 Jul 17. doi: 10.1007/s13691-026-00887-x. Online ahead of print.

bottom of page